News Release

Daily insulin dose, cancer risk among patients with type 1 diabetes

JAMA Oncology

Peer-Reviewed Publication

JAMA Network

About The Study: This study investigated the associations of risk factors with cancer incidence in patients with type 1 diabetes on a daily regimen of insulin.

Authors: Yuanjie Mao, M.D., Ph.D., of Ohio University in Athens, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ 

(doi:10.1001/jamaoncol.2022.2960)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2960?guestAccessKey=b87b1296-2d13-4778-adc8-6ef8cfe9425f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072822


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.